Peritoneal dialysate effluent during peritonitis induces human cardiomyocyte apoptosis by regulating the expression of GATA-4 and Bcl-2 families

Journal of Cellular Physiology
Hsin-Hui WangChing-Yuang Lin

Abstract

Cardiovascular event and infection are leading causes of death from peritoneal dialysis (PD). This study examined in vitro cellular mechanism for cardiotoxicity induced by PD-related peritonitis. Cultured human cardiomyocytes were treated with PD effluent (PDE) during peritonitis (PPDE), and effects of PPDE on cultured cardiomyocytes in terms of apoptosis, with expression its related genes assessed. Results showed PPDE treatment of cardiomyocyte leading to onset of apoptosis, as confirmed by phosphatidylserine exposure plus DNA fragmentation and damage. This apoptosis is mediated by reduced Bcl-2/Bax and Bcl-x(L)/Bax ratios, as well as reduced expression of GATA-4, an important cardiomyocyte survival factor, at the level of transcription. These changes activated pro-apoptotic pathways. PPDE treatment also inhibited ERK signals, contributing to cardiotoxicity. Our findings revealed that PPDE contains potent pro-apoptotic factors that regulate expression of GATA-4 and Bcl-2 families, inducing cultured cardiomyocyte apoptosis. This pinpoints a key role of apoptosis in PD-associated cardiovascular events, along with a potential therapeutic target.

References

Nov 1, 1991·Circulation Research·J Barroso-ArandaJ C Mathison
Jul 1, 1991·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C A FiranekS M Korbet
Aug 1, 1989·Kidney International·J S SilberbergA D Sniderman
Nov 1, 1994·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A LupoA Giangrande
Jul 1, 1996·Annals of Internal Medicine·K ShanJ B Young
Oct 1, 1996·Journal of the American Society of Nephrology : JASN·L F FriedB Piraino
Apr 17, 1997·The New England Journal of Medicine·G OlivettiP Anversa
Mar 21, 1998·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·E Paul, P Devarajan
Jun 20, 1998·Circulation Research·A Haunstetter, S Izumo
Oct 17, 1998·Journal of the American Society of Nephrology : JASN·B Piraino
Jul 8, 1999·Proceedings of the National Academy of Sciences of the United States of America·J NarulaS Kharbanda
Jul 15, 1999·Journal of the American Society of Nephrology : JASN·P S Parfrey, R N Foley
Oct 21, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Z A MassyP Jungers
Mar 31, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·K N LaiJ C Leung
Apr 12, 2001·American Journal of Physiology. Heart and Circulatory Physiology·Z ChenB H Chua
Nov 21, 2001·Current Opinion in Pharmacology·N H BishopricK A Webster
Jul 20, 2002·Cytokine·Cecile AnceyJean-Claude Lecron
Sep 5, 2002·Nature Reviews. Cancer·Suzanne Cory, Jerry M Adams
Dec 7, 2002·The Journal of Biological Chemistry·Kazumi KittaYuichiro J Suzuki
Feb 6, 2004·Life Sciences·Yuichiro J Suzuki, Todd Evans
Apr 22, 2004·Proceedings of the National Academy of Sciences of the United States of America·Anne AriesMona Nemer
Sep 24, 2004·The New England Journal of Medicine·Alan S GoChi-yuan Hsu
Mar 15, 2005·The Journal of Clinical Investigation·Roger S-Y FooRichard N Kitsis
Jun 16, 2005·Kidney International·Areef IshaniRobert N Foley
Aug 23, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Hsin-Hui Wang, Ching-Yuang Lin
Feb 14, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Satoru KobayashiQiangrong Liang
Nov 3, 2006·Kidney International. Supplement·F H BenderB Piraino
Jul 4, 2007·Circulation·Ernesto L SchiffrinJohannes F E Mann
Aug 19, 2007·The Journal of Clinical Investigation·Sandra B HaudekDouglas L Mann
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Nabeel AslamBeth Piraino
Mar 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Kuan-Cheng ChangEduardo Marbán
Jul 11, 2008·Kidney International·Hsin-Hui WangChing-Yuang Lin

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis